Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
734 studies found for:    Open Studies | "Blood Coagulation Disorders"
Show Display Options
Rank Status Study
21 Unknown  "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
Conditions: Myocardial Ischemia;   Blood Coagulation Disorders;   Coronary Artery Disease;   Heart Valve Diseases
Intervention: Drug: Recombinant Activated Factor VII
22 Recruiting Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects
Conditions: Acute Major Bleeding;   Reversal of Coagulopathy
Intervention: Biological: BE1116 (Prothrombin Complex Concentrate)
23 Recruiting Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency
Condition: Benign Prostatic Hyperplasia
Interventions: Procedure: HoLEP;   Procedure: Greenlight laser PVP
24 Recruiting Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Conditions: Hereditary Bleeding Disorder;   Thrombotic Disorder
Intervention:
25 Not yet recruiting The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders
Condition: Chronic Subdural Hematoma
Interventions: Drug: Atorvastatin;   Drug: Atorvastatin and Dexamethasone
26 Recruiting The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
Condition: Glanzmann Thrombasthenia
Intervention:
27 Recruiting Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol
28 Recruiting Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: nonacog beta pegol
29 Recruiting To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
30 Recruiting Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
31 Recruiting Hemostatic Complications in Hematopoietic Stem Cell Transplantation
Condition: Hemostatic Disorders
Intervention: Drug: thrombopoietin, interleukin-11, heparin,
32 Recruiting Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)
Conditions: Trauma;   Injury;   Bleeding;   Haemorrhage;   Coagulopathy
Interventions: Drug: Fibrinogen concentrate;   Drug: Placebo Comparator
33 Recruiting Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
Condition: Coagulation Defects
Interventions: Biological: Spray-dried S/D-treated Plasma;   Drug: Spray-dried S/D-treated plasma
34 Not yet recruiting Post-Marketing Requirement to Evaluate the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation With Special Emphasis on Hyperfibrinolysis.
Conditions: Coagulopathy;   Endstage Liver Disease
Interventions: Biological: Octaplas™;   Biological: Plasma
35 Unknown  RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
Condition: Major Trauma
Interventions: Drug: Fibrinogen concentrate, Prothrombin complex concentrate and FXIII concentrate;   Drug: Fresh Frozen Plasma blood type 0, A, B and AB
36 Recruiting Point-of-Care Testing in Coagulopathic Patients Undergoing Cardiac Surgery - a Multicenter Study
Condition: Coagulopathy During Cardiac Surgery
Interventions: Device: Conventional laboratory testing (Central laboratory);   Device: POC testing
37 Not yet recruiting Coagulopathy and SIRS During ECC in Intensive Care
Condition: Disorder of Circulatory System
Intervention: Device: ECLS
38 Recruiting Standardisation of Investigations of Mild Bleeding Disorders
Condition: Hemorrhagic Disorders
Intervention: Other: Second step of investigations
39 Not yet recruiting Efficacy and Safety of Heparin-grafted Membrane for CRRT
Conditions: Acute Kidney Injury;   Hemorrhage;   Coagulopathy
Interventions: Device: oXiris as first filter;   Device: M150 as first filter
40 Not yet recruiting Open-label, Multicenter, Post-Marketing Requirement Study to Investigate Safety, Tolerability and Efficacy of octaplasLG in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors
Conditions: Liver or Cardiac Surgery;   Liver Dysfunction;   Coagulopathy
Intervention: Biological: octaplasLG

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years